XFOR X4 Pharmaceuticals, Inc. - Common Stock
XFOR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
XFOR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
XFOR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 5 45,5%
- Al 5 45,5%
- Tut 1 9,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-08-18Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.13 | $-0.18 | 0.05% |
| 31 Mart 2026 | $-0.16 | $-0.20 | 0.04% |
| 31 Aralık 2025 | $-0.22 | $-0.35 | 0.13% |
| 30 Eylül 2025 | $-0.69 | $-0.93 | 0.24% |
| 30 Haziran 2025 | $-3.47 | $-4.42 | 0.95% |
| 31 Mart 2025 | $0.04 | $-4.53 | 4.6% |
| 31 Aralık 2024 | $-6.00 | $-5.36 | -0.65% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| PALI | $375M | -7.8 | — | — | -25.4% | — |
| RCKT | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | -15,232,980 | 43,272,773 | 7,412,990 | 6,840,035 | -13,341,171 | 6,695,509 | 6,681,349 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | -15,262,029 | 43,272,773 | 7,412,990 | 6,869,084 | -13,353,198 | 6,695,509 | 6,693,376 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
Bilanço 25
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
Nakit Akışı 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-92M | $-76M | · | $-92M | $29M | $3M | · | $66.0K | $-19M | $-134M | · | $-104M | $-123M | $-89M | · | $-85M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | -1.0 | -1.0 | · | -0.4 | 0.4 | 19.7 | · | 64.7 | 3.2 | -5.0 | · | -43.0 | -43.1 | -15.0 | · | -21.9 | |
| P/S | 55.0 | 58.1 | · | 18.0 | 4.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| P / FCF | · | · | · | · | · | -3.3 | · | · | · | -208.1 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -193.1 | · | · | · | -171.7 | |
| Earnings Yield | -95.3% | -103.6% | · | -280.7% | 245.3% | 5.1% | · | 1.5% | 31.4% | -19.8% | · | -2.3% | -2.3% | -6.7% | · | -4.6% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $6M | $3M | $0 | $0 | $0 |
| Faaliyet Kâr Marjı % | -1336.7% | -1423.6% | — | — | — |
| Net Gelir | $-79M | $-37M | $-101M | $-94M | $-89M |
| Seyreltilmiş Hisse Başı Kâr | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | 1.1 | 0.5 | 0.5 |
| Cari Oran | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| Cari Oran | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-86M | $-131M | $-97M | $-77M | $-72M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 92 dosya · $429.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 38 (+24 önceki Ç'ye göre) | 25 (+16 önceki Ç'ye göre) | 19 (-2 önceki Ç'ye göre) | 13 (-7 önceki Ç'ye göre) | +7.8M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| MORGAN STANLEY | $44.014.736 | 9.424.997 | 10,25% | Hisse senetleri |
| FMR LLC | $38.862.138 | 8.321.657 | 9,05% | Hisse senetleri |
| Bain Capital Life Sciences Investors, LLC | $37.208.011 | 7.967.454 | 8,66% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $37.049.403 | 7.933.491 | 8,63% | Hisse senetleri |
| Saturn V Capital Management LP | $32.565.512 | 6.973.343 | 7,58% | Hisse senetleri |
| Empery Asset Management, LP | $32.365.860 | 6.930.591 | 7,54% | Hisse senetleri |
| Deep Track Capital, LP | $27.453.795 | 5.878.757 | 6,39% | Hisse senetleri |
| Kalehua Capital Management LLC | $17.385.663 | 3.722.840 | 4,05% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.353.062 | 3.715.859 | 4,04% | Hisse senetleri |
| Rosalind Advisors, Inc. | $15.012.957 | 3.214.766 | 3,50% | Hisse senetleri |
| BRAIDWELL LP | $13.649.261 | 2.922.754 | 3,18% | Hisse senetleri |
| Blackstone Inc. | $12.524.576 | 2.681.922 | 2,92% | Hisse senetleri |
| Trails Edge Capital Partners, LP | $12.008.803 | 2.571.478 | 2,80% | Hisse senetleri |
| VANGUARD GROUP INC | $11.639.808 | 2.909.952 | 2,71% | Hisse senetleri |
| Nantahala Capital Management, LLC | $11.439.016 | 2.449.468 | 2,66% | Hisse senetleri |
| BVF INC/IL | $10.431.575 | 2.233.742 | 2,43% | Hisse senetleri |
| Venrock Adviser, LLC | $9.032.962 | 1.934.253 | 2,10% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $8.383.316 | 1.794.568 | 1,95% | Hisse senetleri |
| SAMSARA BIOCAPITAL, LLC | $6.517.391 | 1.395.587 | 1,52% | Hisse senetleri |
| STATE STREET CORP | $6.052.399 | 1.296.017 | 1,41% | Hisse senetleri |
| Woodline Partners LP | $4.675.114 | 1.001.095 | 1,09% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $4.280.223 | 916.536 | 1,00% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.671.417 | 572.038 | 0,62% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.531.738 | 542.128 | 0,59% | Hisse senetleri |
| Verdad Advisers, LP | $1.644.274 | 352.093 | 0,38% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.229.443 | 263.264 | 0,29% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.168.901 | 250.300 | 0,27% | Alım opsiyonu |
| Caption Management, LLC | $1.167.500 | 250.000 | 0,27% | Alım opsiyonu |
| Stonepine Capital Management, LLC | $1.050.699 | 224.989 | 0,24% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $677.150 | 145.000 | 0,16% | Hisse senetleri |
| Nuveen, LLC | $501.507 | 107.389 | 0,12% | Hisse senetleri |
| ALPS ADVISORS INC | $447.040 | 95.726 | 0,10% | Hisse senetleri |
| RHUMBLINE ADVISERS | $444.022 | 95.081 | 0,10% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $407.607 | 87.282 | 0,09% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $368.393 | 78.885 | 0,09% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $349.293 | 74.795 | 0,08% | Hisse senetleri |
| Bank of New York Mellon Corp | $327.507 | 70.130 | 0,08% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $316.215 | 67.712 | 0,07% | Hisse senetleri |
| Palumbo Wealth Management LLC | $313.432 | 67.116 | 0,07% | Hisse senetleri |
| Squarepoint Ops LLC | $313.254 | 67.078 | 0,07% | Hisse senetleri |
| CITIGROUP INC | $305.633 | 65.446 | 0,07% | Hisse senetleri |
| MetLife Investment Management, LLC | $224.015 | 47.969 | 0,05% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $218.841 | 46.861 | 0,05% | Hisse senetleri |
| Point72 Asset Management, L.P. | $191.806 | 41.072 | 0,04% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173.131 | 37.073 | 0,04% | Hisse senetleri |
| Jump Financial, LLC | $159.961 | 34.253 | 0,04% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $154.003 | 32.977 | 0,04% | Hisse senetleri |
| Invesco Ltd. | $150.575 | 32.243 | 0,04% | Hisse senetleri |
| JPMORGAN CHASE & CO | $141.785 | 33.519 | 0,03% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $111.361 | 23.846 | 0,03% | Hisse senetleri |
| AXQ CAPITAL, LP | $106.850 | 22.880 | 0,02% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $103.128 | 22.083 | 0,02% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $90.719 | 19.426 | 0,02% | Hisse senetleri |
| STIFEL FINANCIAL CORP | $86.483 | 18.519 | 0,02% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $84.527 | 18.100 | 0,02% | Hisse senetleri |
| INTECH INVESTMENT MANAGEMENT LLC | $80.744 | 17.290 | 0,02% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $77.055 | 16.500 | 0,02% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $77.055 | 16.500 | 0,02% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $76.513 | 16.384 | 0,02% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $73.963 | 15.838 | 0,02% | Hisse senetleri |
| BARCLAYS PLC | $72.707 | 15.569 | 0,02% | Hisse senetleri |
| CAXTON CORP | $72.650 | 15.557 | 0,02% | Hisse senetleri |
| WINTON GROUP Ltd | $67.248 | 14.400 | 0,02% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65.614 | 14.050 | 0,02% | Hisse senetleri |
| Creative Planning | $64.782 | 13.872 | 0,02% | Hisse senetleri |
| BlackRock, Inc. | $64.208 | 13.749 | 0,01% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $60.215 | 14.580 | 0,01% | Hisse senetleri |
| NORTHERN TRUST CORP | $59.323 | 12.703 | 0,01% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $58.375 | 12.500 | 0,01% | Hisse senetleri |
| ProShare Advisors LLC | $49.445 | 10.588 | 0,01% | Hisse senetleri |
| Indivisible Partners | $46.850 | 10.000 | 0,01% | Hisse senetleri |
| Pettinga Financial Advisors LLC | $46.700 | 10.000 | 0,01% | Hisse senetleri |
| Legal & General Group Plc | $36.697 | 7.858 | 0,01% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $36.169 | 7.745 | 0,01% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $34.268 | 7.338 | 0,01% | Hisse senetleri |
| ROYAL BANK OF CANADA | $12.000 | 2.559 | 0,00% | Hisse senetleri |
| Point72 Asia (Singapore) Pte. Ltd. | $9.966 | 2.914 | 0,00% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $8.215 | 1.759 | 0,00% | Hisse senetleri |
| Sterling Capital Management LLC | $7.607 | 1.629 | 0,00% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $7.408 | 2.166 | 0,00% | Hisse senetleri |
| Russell Investments Group, Ltd. | $3.404 | 729 | 0,00% | Hisse senetleri |
| GROUP ONE TRADING LLC | $3.325 | 712 | 0,00% | Hisse senetleri |
| Bleichroeder LP | $2.779 | 595 | 0,00% | Hisse senetleri |
| Blue Trust, Inc. | $1.326 | 284 | 0,00% | Hisse senetleri |
| GSA CAPITAL PARTNERS LLP | $356 | 76.314 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $310 | 66.379 | 0,00% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $154 | 33 | 0,00% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $153 | 38 | 0,00% | Hisse senetleri |
| UBS Group AG | $149 | 32 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $140 | 30 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $42 | 9 | 0,00% | Hisse senetleri |
| HighMark Wealth Management LLC | $28 | 6 | 0,00% | Hisse senetleri |
Şirket yöneticileri 27 içeriden öğrenenler · 7 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 17 Haziran 2019 A | 237.294 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 27 Kasım 2018 A | 250.000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 30 Haziran 2026 S | 167.750 | 0 | 1 | $-36.393 |
| Adam S. Mostafa | CFO and Treasurer | 17 Haziran 2019 A | 10.564 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 24 Nisan 2019 A | — | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 07 Mart 2018 A | — | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 07 Mart 2018 A | — | 0 | 0 | $0 |
| Kelly Gold | Yönetim kurulu üyesi | 01 Temmuz 2026 A | — | 0 | 0 | $0 |
| William Aliski | Yönetim kurulu üyesi | 18 Eylül 2019 A | — | 0 | 0 | $0 |
| Rene Russo | Yönetim kurulu üyesi | 17 Haziran 2019 A | — | 0 | 0 | $0 |
| David W J Mcgirr | Yönetim kurulu üyesi | 17 Haziran 2019 A | — | 0 | 0 | $0 |
| Murray Stewart | Yönetim kurulu üyesi | 29 Mart 2019 A | — | 0 | 0 | $0 |
| Gary Bridger | Yönetim kurulu üyesi | 13 Mart 2019 A | — | 0 | 0 | $0 |
| Michael S Wyzga | Yönetim kurulu üyesi | 13 Mart 2019 A | — | 0 | 0 | $0 |
| Isaac Blech | Yönetim kurulu üyesi | 13 Mart 2019 A | — | 0 | 0 | $0 |
| Tillman U. Gerngross | Yönetim kurulu üyesi | 05 Haziran 2018 A | 392.821 | 0 | 0 | $0 |
| Claudio Nessi | Yönetim kurulu üyesi | 05 Haziran 2018 A | 867.639 | 0 | 0 | $0 |
| Amy Schulman | Yönetim kurulu üyesi | 05 Haziran 2018 A | — | 0 | 0 | $0 |
| William D Clark | Yönetim kurulu üyesi | 05 Haziran 2018 A | — | 0 | 0 | $0 |
| GORDON CARL L | Yönetim kurulu üyesi | 05 Haziran 2018 A | 1.868.966 | 0 | 0 | $0 |
| Terrance McGuire | Yönetim kurulu üyesi | 05 Haziran 2018 A | 18.031 | 0 | 0 | $0 |
| Michael Jay Ross | Yönetim kurulu üyesi | 15 Kasım 2017 A | 1.868.961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | 10% sahip | 20 Kasım 2017 C | 124.381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10% sahip | 20 Kasım 2017 C | 722.179 | 0 | 0 | $0 |
| John Volpone | — | 12 Ağustos 2026 S | 265.305 | 0 | 1 | $-109.117 |
| Adam R Craig | — | 12 Ağustos 2026 S | 328.651 | 0 | 1 | $-210.616 |
| Anthony Chris Stevens | — | 07 Mart 2018 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 10 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 başvurular | 29 Ekim 2025 | 6,20% | Değişiklik | Pasif yatırım | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 18 Ağustos 2025 | 9,99% | İlk başvuru | — | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 13 Ağustos 2025 | 9,99% | İlk başvuru | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 başvurular | 17 Temmuz 2019 | — | İlk başvuru | — | SEC |
| 28 Mayıs 2019 | — | İlk başvuru | — | SEC | |
| Paula Ragan, Ph.D. ×2 başvurular | 26 Nisan 2019 | — | İlk başvuru | M&A / satış | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 başvurular | 19 Mart 2019 | — | İlk başvuru | — | SEC |
| X4 Pharmaceuticals, Inc. | 06 Aralık 2018 | — | İlk başvuru | M&A / satış | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 14 Şubat 2018 | — | İlk başvuru | Pasif yatırım | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 29 Kasım 2017 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 13 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 25.945 SH | 08 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,08% | 275.116 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,02% | 750.719 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70.293 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 1.950.293 SH | 08 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 464.950 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 46.744 NS | 31 Mayıs 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 30.148 SH | 08 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.031.672 SH | 08 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.599.387 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.885 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,00% | 1 NS | 31 Mayıs 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 1 NS | 31 Mayıs 2026 | N-PORT |